| |
|
|
| |
|
|
| |
|
|
 |
|
Barofold
Business: BaroFold applies its patented protein folding technology to improve the efficacy and lower the cost of protein therapeutics.
Co-investors: HBM Partners |
| |
|
|
| |
|
|
 |
|
BiOptix
Business: BiOptix sells a label-free analytical instrument for the real-time detection of biological samples.
Co-investors: Rusnano |
| |
|
|
| |
|
|
 |
|
Millennium Pharmacy Systems
Business: Millennium Pharmacy Systems offers technology-enabled institutional pharmacy services.
Co-investors: CHL Medical Partners, Essex Woodlands Health Ventures, Ascension Health Ventures
|
| |
|
|
| |
|
|
 |
|
MiRagen Therapeutics
Business: Miragen Therapeutics is developing innovative microRNA-based therapeutics for cardiovascular and muscle disease.
Co-investors: Atlas Venture, Amgen Ventures, Broadview Ventures
|
| |
|
|
| |
|
|
 |
|
ARCA biopharma
Business: Drug discovery based on pharmacogenomics of heart disease.
Outcome: IPO (NASDAQ:ABIO) January, 2009.
Co-investors: Atlas Venture, Skyline Ventures, InterWest Partners |
| |
|
|
| |
|
|
 |
|
Array BioPharma
Business: Array is a discovery research organization that sells chemicals and services to the pharmaceutical industry.
Outcome: IPO (NASDAQ:ARRY) November, 2000.
Co-investors: Falcon Technology Partners; Frazier & Co.; ARCH Ventures; Advent International |
| |
|
|
| |
|
|
 |
|
Dharmacon
Business: Leading supplier worldwide of synthetic RNA
Outcome: Sold to Fisher Scientific (NYSE:FSH) March, 2004.
Co-investors: Telegraph Hill Partners |
| |
|
|
| |
|
|
 |
|
Entelos
Business: Entelos software and services offer decision-support and disease knowledge management for biopharmaceutical researchers.
Outcome: IPO on London AIM April, 2006.
Co-investors: Abingworth Management, Charles River Partners, Versant Ventures
|
| |
|
|
| |
|
|
 |
|
Genomica
Business: Genomica's database software, Discovery Manager, allows researchers to organize and analyze genetic sequences for drug discovery.
Outcome: IPO (NASDAQ:GNOM); Sold to Exelixis November, 2001.
Co-investors: Falcon Technology Partners, ARCH Venture Partners, INVESCO Trust Company |
| |
|
|
| |
|
|
